The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
Genomics and Signaling Pathways in Hepatocellular Carcinoma
Abstract
Hepatocellular carcinoma (HCC) is a leading cause of death among cirrhotic patients and has become a major health problem in developed countries. There is an elemental understanding of the genes and signaling pathways involved in the initiation and progression of this neoplasm. The current hypothesis of the HCC cell origin includes both somatic cells (hepatocytes) and stem cells/progenitor cells. Unlike that in other malignancies such as breast, brain, or hematopoietic cancers, the implication of cancer stem cells in HCC pathogenesis is not yet supported by consistent data. Analysis of somatic genetic alterations and gene expression profiles in HCC samples has provided relevant information on the genes involved in hepatocarcinogenesis, pinpointing a seminal molecular classification of the disease. Nonetheless, a comprehensive genomic analysis of HCC samples using high-resolution platforms in precisely annotated HCCs is clearly needed. Recent data have identified different signaling pathways in liver carcinogenesis (e.g., Wnt-betaCatenin, Hedgehog, tyrosine kinase receptor-related pathways), providing an important potential source of novel molecular targets for new therapies. This review summarizes the most relevant information regarding structural and functional alterations in HCC and describes some of the key signaling pathways implicated in hepatocarcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Finishing the euchromatic sequence of the human genome
International Human Genome Sequencing Consortium (2004) · Nature · doi:10.1038/nature03001 · Cited by 4,971
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
Samuels, Y., Wang, Z., Bardelli, A., Silliman, N., Ptak, J., Szabo, S., Yan, H., Gazdar, A., Powell, S. M., Riggins, G. J., et al. (2004) · Science · doi:10.1126/science.1096502 · Cited by 3,437
ERBB receptors and cancer: the complexity of targeted inhibitors
Hynes, N. E., & Lane, H. A. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1609 · Cited by 3,313
Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
Kallioniemi, A., Kallioniemi, O.-P., Sudar, D., Rutovitz, D., Gray, J. W., Waldman, F., & Pinkel, D. (1992) · Science · doi:10.1126/science.1359641 · Cited by 3,297
Llovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
Self-citationCobleigh, M. A., Vogel, C. L., Tripathy, D., Robert, N. J., Scholl, S., Fehrenbacher, L., Wolter, J. M., Paton, V., Shak, S., Lieberman, G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2639 · Cited by 2,765
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Socializing with the Neighbors
Fuchs, E., Tumbar, T., & Guasch, G. (2004) · Cell · doi:10.1016/s0092-8674(04)00255-7 · Cited by 1,719
Jordan, C. T., Guzman, M. L., & Noble, M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra061808 · Cited by 1,702
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?
Baylin, S. B., & Ohm, J. E. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1799 · Cited by 1,639
Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways
Sordella, R., Bell, D. W., Haber, D. A., & Settleman, J. (2004) · Science · doi:10.1126/science.1101637 · Cited by 1,606
Caught up in a Wnt storm: Wnt signaling in cancer
Giles, R. H., van Es, J. H., & Clevers, H. (2003) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(03)00005-2 · Cited by 1,482
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis
Thayer, S. P., di Magliano, M. P., Heiser, P. W., Nielsen, C. M., Roberts, D. J., Lauwers, G. Y., Qi, Y. P., Gysin, S., Castillo, C. F.-D., Yajnik, V., et al. (2003) · Nature · doi:10.1038/nature02009 · Cited by 1,480
Molecular pathogenesis of human hepatocellular carcinoma
Thorgeirsson, S. S., & Grisham, J. W. (2002) · Nature Genetics · doi:10.1038/ng0802-339 · Cited by 1,439
Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
Bressac, B., Kew, M., Wands, J., & Ozturk, M. (1991) · Nature · doi:10.1038/350429a0 · Cited by 1,432
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
Yu, H. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1472 · Cited by 1,424
Asymmetric and symmetric stem-cell divisions in development and cancer
Morrison, S. J., & Kimble, J. (2006) · Nature · doi:10.1038/nature04956 · Cited by 1,410
The Hedgehog and Wnt signalling pathways in cancer
Taipale, J., & Beachy, P. A. (2001) · Nature · doi:10.1038/35077219 · Cited by 1,393
Cancer stem cells: an old idea–a paradigm shift
Wicha, M. S., Liu, S., & Dontu, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3153 · Cited by 1,378
The tor pathway: a target for cancer therapy
Bjornsti, M.-A., & Houghton, P. J. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1362 · Cited by 1,314
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours
Berman, D. M., Karhadkar, S. S., Maitra, A., Montes de Oca, R., Gerstenblith, M. R., Briggs, K., Parker, A. R., Shimada, Y., Eshleman, J. R., Watkins, D. N., et al. (2003) · Nature · doi:10.1038/nature01972 · Cited by 1,251
PIK3CA is implicated as an oncogene in ovarian cancer
Shayesteh, L., Lu, Y., Kuo, W.-L., Baldocchi, R., Godfrey, T., Collins, C., Pinkel, D., Powell, B., Mills, G. B., & Gray, J. W. (1999) · Nature Genetics · doi:10.1038/5042 · Cited by 1,155
Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
Coste, A. D. L., Romagnolo, B., Billuart, P., Renard, C.-A., Buendia, M.-A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8847 · Cited by 1,121
Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer
Watkins, D. N., Berman, D. M., Burkholder, S. G., Wang, B., Beachy, P. A., & Baylin, S. B. (2003) · Nature · doi:10.1038/nature01493 · Cited by 1,082
DNA Microarray Technology: Devices, Systems, and Applications
Heller, M. J. (2002) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.4.020702.153438 · Cited by 1,068
Prediction of cancer outcome with microarrays: a multiple random validation strategy
Michiels, S., Koscielny, S., & Hill, C. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17866-0 · Cited by 1,025
Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer.
Sparks, A. B., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · PubMed · Cited by 1,008
Hepatocellular carcinoma: Recent trends in the United States
El-Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.013 · Cited by 972
Satoh, S., Daigo, Y., Furukawa, Y., Kato, T., Miwa, N., Nishiwaki, T., Kawasoe, T., Ishiguro, H., Fujita, M., Tokino, T., et al. (2000) · Nature Genetics · doi:10.1038/73448 · Cited by 960
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling
Lee, J.-S., Chu, I.-S., Heo, J., Calvisi, D. F., Sun, Z., Roskams, T., Durnez, A., Demetris, A. J., & Thorgeirsson, S. S. (2004) · Hepatology · doi:10.1002/hep.20375 · Cited by 922
The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway
Sansal, I., & Sellers, W. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.141 · Cited by 921
Gene Expression Patterns in Human Liver Cancers
Chen, X., Cheung, S. T., So, S., Fan, S. T., Barry, C., Higgins, J., Lai, K.-M., Ji, J., Dudoit, S., Ng, I. O. L., et al. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.02-02-0023 · Cited by 878
Ye, Q.-H., Qin, L.-X., Forgues, M., He, P., Kim, J. W., Peng, A. C., Simon, R., Li, Y., Robles, A. I., Chen, Y., et al. (2003) · Nature Medicine · doi:10.1038/nm843 · Cited by 850
Petit, A. M. V., Rak, J. W., Hung, M., Rockwell, P., Goldstein, N. I., FENDLY, B. M., & Kerbel, R. S. (1997) · Europe PMC (PubMed Central) · Cited by 836
Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic
Kang, S., Bader, A. G., & Vogt, P. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408864102 · Cited by 823
Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade
Berman, D. M., Karhadkar, S. S., Hallahan, A. R., Pritchard, J. I., Eberhart, C. G., Watkins, D. N., Chen, J. K., Cooper, M. K., Taipale, J., Olson, J. M., et al. (2002) · Science · doi:10.1126/science.1073733 · Cited by 803
Huber, A. H., & Weis, W. I. (2001) · Cell · doi:10.1016/s0092-8674(01)00330-0 · Cited by 777
Zucman-Rossi, J., Jeannot, E., Van Nhieu, J. T., Scoazec, J.-Y., Guettier, C., Rebouissou, S., Bacq, Y., Leteurtre, E., Paradis, V., Michalak, S., et al. (2006) · Hepatology · doi:10.1002/hep.21068 · Cited by 760
Liver regeneration and repair: Hepatocytes, progenitor cells, and stem cells
Fausto, N. (2004) · Hepatology · doi:10.1002/hep.20214 · Cited by 720
Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex
Lepourcelet, M., Chen, Y.-N. P., France, D. S., Wang, H., Crews, P., Petersen, F., Bruseo, C., Wood, A. W., & Shivdasani, R. A. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00334-9 · Cited by 653
The role of hepatocytes and oval cells in liver regeneration and repopulation
Fausto, N., & Campbell, J. S. (2003) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00338-6 · Cited by 648
Whang, Y. E., Wu, X., Suzuki, H., Reiter, R. E., Tran, C., Vessella, R. L., Said, J. W., Isaacs, W. B., & Sawyers, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5246 · Cited by 639
mTOR-targeted therapy of cancer with rapamycin derivatives
Vignot, S., Faivre, S., Aguirre, D., & Raymond, E. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi113 · Cited by 617
Laurent–Puig, P., Legoix, P., Bluteau, O., Belghiti, J., Franco, D., Binot, F., Monges, G., Thomas, G., Bioulac–Sage, P., & Zucman–Rossi, J. (2001) · Gastroenterology · doi:10.1053/gast.2001.24798 · Cited by 582
Focus on hepatocellular carcinoma
Bruix, J., Boix, L., Sala, M., & Llovet, J. M. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00058-3 · Cited by 570
Self-citationHorizontal transfer of oncogenes by uptake of apoptotic bodies
Bergsmedh, A., Szeles, A., Henriksson, M., Bratt, A., Folkman, M. J., Spetz, A.-L., & Holmgren, L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101129998 · Cited by 550
Okabe, H., Satoh, S., Kato, T., Kitahara, O., Yanagawa, R., Yamaoka, Y., Tsunoda, T., Furukawa, Y., & Nakamura, Y. (2001) · PubMed · Cited by 546
Miyoshi, Y., Iwao, K., Nagasawa, Y., Aihara, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T., & Nakamura, Y. (1998) · PubMed · Cited by 514
Iizuka, N., Oka, M., Yamada-Okabe, H., Nishida, M., Maeda, Y., Mori, N., Takao, T., Tamesa, T., Tangoku, A., Tabuchi, H., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12775-4 · Cited by 511
VEGFs, receptors and angiogenesis
Veikkola, T., & Alitalo, K. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0091 · Cited by 508
PTEN/MMAC1 mutations in endometrial cancers.
Risinger, J. I., Hayes, A. K., Berchuck, A., & Barrett, J. C. (1997) · PubMed · Cited by 506
PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas
Lee, J. W., Soung, Y. H., Kim, S. Y., Lee, H. W., Park, W. S., Nam, S. W., Kim, S. H., Lee, J. Y., Yoo, N. J., & Lee, S. H. (2005) · Oncogene · doi:10.1038/sj.onc.1208304 · Cited by 506
Mutational spectrum of β-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas
Taniguchi, K., Roberts, L. R., Aderca, I. N., Dong, X., Qian, C., Murphy, L. M., Nagorney, D. M., Burgart, L. J., Roche, P. C., Smith, D. I., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205591 · Cited by 486
Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer
Philip, P. A., Mahoney, M. R., Allmer, C., Thomas, J., Pitot, H. C., Kim, G., Donehower, R. C., Fitch, T., Picus, J., & Erlichman, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.696 · Cited by 462
The new cytogenetics: blurring the boundaries with molecular biology
Speicher, M. R., & Carter, N. P. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1692 · Cited by 458
Liver stem cells and their implication in hepatocellular and cholangiocarcinoma
Roskams, T. (2006) · Oncogene · doi:10.1038/sj.onc.1209558 · Cited by 422
Cancer-specific mutations in PIK3CA are oncogenic in vivo
Bader, A. G., Kang, S., & Vogt, P. K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510857103 · Cited by 420
Expression of vascular endothelial growth factor in human hepatocellular carcinoma
Yamaguchi, R., Yano, H., Iemura, A., Ogasawara, S., Haramaki, M., & Kojiro, M. (1998) · Hepatology · doi:10.1002/hep.510280111 · Cited by 397
Heterogeneity and plasticity of hepatocyte lineage cells
Sell, S. (2001) · Hepatology · doi:10.1053/jhep.2001.21900 · Cited by 396
Dysregulation of growth factor signaling in human hepatocellular carcinoma
Breuhahn, K., Longerich, T., & Schirmacher, P. (2006) · Oncogene · doi:10.1038/sj.onc.1209556 · Cited by 391
Llovet, J. M., Chen, Y., Wurmbach, E., Roayaie, S., Fiel, M. I., Schwartz, M., Thung, S. N., Khitrov, G., Zhang, W., Villanueva, A., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.014 · Cited by 386
Self-citationmTOR and P70 S6 Kinase Expression in Primary Liver Neoplasms
Sahin, F., Kannangai, R., Adegbola, O., Wang, J., Su, G., & Torbenson, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0941 · Cited by 382
From signatures to models: understanding cancer using microarrays
Segal, E., Friedman, N., Kaminski, N., Regev, A., & Koller, D. (2005) · Nature Genetics · doi:10.1038/ng1561 · Cited by 381
Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas.
Murakami, Y., Hayashi, K., Hirohashi, S., & Sekiya, T. (1991) · PubMed · Cited by 374
Xu, X.-R., Huang, J., Xu, Z.-G., Qian, B.-Z., Zhu, Z.-D., Yan, Q., Cai, T., Zhang, X., Xiao, H.-S., Qu, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241522398 · Cited by 365
M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity
De Souza, A. T., Hankins, G. R., Washington, M. K., Orton, T. C., & Jirtle, R. L. (1995) · Nature Genetics · doi:10.1038/ng1295-447 · Cited by 355
Differential molecular interactions of β-catenin and plakoglobin in adhesion, signaling and cancer
Ben-Ze'ev, A., & Geiger, B. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80039-2 · Cited by 341
Schiffer, E., Housset, C., Cacheux, W., Wendum, D., Desbois‐Mouthon, C., Rey, C., Clergue, F., Poupon, R., Barbu, V., & Rosmorduc, O. (2005) · Hepatology · doi:10.1002/hep.20538 · Cited by 340
Horizontal Transfer of DNA by the Uptake of Apoptotic Bodies
Holmgren, L., Szeles, A., Rajnavölgyi, E., Folkman, J., Klein, G., Ernberg, I., & Falk, K. I. (1999) · Blood · doi:10.1182/blood.v93.11.3956 · Cited by 333
Genetics of hepatocellular carcinoma
Annick Buendia, M. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0319 · Cited by 329
Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma
Ito, Y., Takeda, T., Sakon, M., Tsujimoto, M., Higashiyama, S., Noda, K., Miyoshi, E., Monden, M., & Matsuura, N. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1580 · Cited by 321
The prognostic molecular markers in hepatocellular carcinoma
Qin, L.-X. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i3.385 · Cited by 311
Mise, M., Arii, S., Higashituji, H., Furutani, M., Niwano, M., Harada, T., Ishigami, S., Toda, Y., Nakayama, H., Fukumoto, M., et al. (1996) · Hepatology · doi:10.1002/hep.510230309 · Cited by 307
Hepatic stem cells in liver regeneration
Thorgeirsson, S. S. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.11.8836038 · Cited by 305
Knight, B., Yeoh, G. C. T., Husk, K. L., Ly, T., Abraham, L. J., Yu, C., Rhim, J. A., & Fausto, N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1809 · Cited by 301
Baselga, J. M., Tripathy, D., Mendelsohn, J., Baughman, S. A., Benz, C. C., Dantis, L., Sklarin, N. T., Seidman, A. D., Hudis, C. A., Moore, J. L., et al. (1999) · PubMed · Cited by 300
Nhieu, J. T. V., Renard, C. A., Wei, Y., Cherqui, D., Zafrani, E. S., & Buendia, M. A. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65168-1 · Cited by 295
Hsu, H.-C., Jeng, Y.-M., Mao, T.-L., Chu, J.-S., Lai, P.-L., & Peng, S.-Y. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64590-7 · Cited by 294
Chemical Approaches for Functionally Probing the Proteome
Greenbaum, D., Baruch, A., Hayrapetian, L., Darula, Z., Burlingame, A., Medzihradszky, K. F., & Bogyo, M. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.t100003-mcp200 · Cited by 291
High frequency of Ki‐ras codon 12 mutations in pancreatic adenocarcinomas
Grünewald, K., Lyons, J., Fröhlich, A., Feichtinger, H., Weger, R. A., Schwab, G., Janssen, J. W. G., & Bartram, C. R. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430614 · Cited by 290
Origin and Structural Evolution of the Early Proliferating Oval Cells in Rat Liver
Paku, S., Schnur, J., Nagy, P., & Thorgeirsson, S. S. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64082-5 · Cited by 286
Wong, N., Lai, P., Lee, S.-W., Fan, S., Pang, E., Liew, C.-T., Sheng, Z., Lau, J. W.-Y., & Johnson, P. J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65248-0 · Cited by 275
Huang, H., Fujii, H., Sankila, A., Mahler-Araujo, B. M., Matsuda, M., Cathomas, G., & Ohgaki, H. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65496-x · Cited by 274
Comprehensive allelotyping of human hepatocellular carcinoma
Nagai, H., Pineau, P., Tiollais, P., Buendia, M. A., & Dejean, A. (1997) · Oncogene · doi:10.1038/sj.onc.1201136 · Cited by 274
Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis
Sicklick, J. K., Li, Y.-X., Jayaraman, A., Kannangai, R., Qi, Y., Vivekanandan, P., Ludlow, J. W., Owzar, K., Chen, W., Torbenson, M. S., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi292 · Cited by 270
Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
Tanaka, S., Mori, M., Sakamoto, Y., Makuuchi, M., Sugimachi, K., & Wands, J. R. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4891 · Cited by 256
The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas
Kanai, Y., Ushijima, S., Hui, A.-M., Ochiai, A., Tsuda, H., Sakamoto, M., & Hirohashi, S. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970502)71:3<355::aid-ijc8>3.0.co;2-x · Cited by 253
Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma
Merle, P., de la Monte, S., Kim, M., Herrmann, M., Tanaka, S., Von Dem Bussche, A., Kew, M. C., Trepo, C., & Wands, J. R. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.009 · Cited by 249
Activation of the hedgehog pathway in human hepatocellular carcinomas
Huang, S., He, J., Zhang, X., Bian, Y., Yang, L., Xie, G., Zhang, K., Tang, W., Stelter, A. A., Wang, Q., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi378 · Cited by 244
Mouse A6-Positive Hepatic Oval Cells Also Express Several Hematopoietic Stem Cell Markers
Petersen, B. E., Grossbard, B., Hatch, H., Pi, L., Deng, J., & Scott, E. W. (2003) · Hepatology · doi:10.1053/jhep.2003.50104 · Cited by 235
Genetic regulators of large-scale transcriptional signatures in cancer
Adler, A. S., Lin, M., Horlings, H., Nuyten, D. S. A., van de Vijver, M. J., & Chang, H. Y. (2006) · Nature Genetics · doi:10.1038/ng1752 · Cited by 231
Ueki, T., Fujimoto, J., Suzuki, T., Yamamoto, H., & Okamoto, E. (1997) · Hepatology · doi:10.1002/hep.510250413 · Cited by 226
Hematopoietic cells as hepatocyte stem cells: A critical review of the evidence†
Thorgeirsson, S. S., & Grisham, J. W. (2006) · Hepatology · doi:10.1002/hep.21015 · Cited by 226
Nakanishi, K., Sakamoto, M., Yamasaki, S., Todo, S., & Hirohashi, S. (2005) · Cancer · doi:10.1002/cncr.20774 · Cited by 222
Smela, M. E., Hamm, M. L., Henderson, P. T., Harris, C. M., Harris, T. M., & Essigmann, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.102167699 · Cited by 210
Kusano, N., Shiraishi, K., Kubo, K., Oga, A., Okita, K., & Sasaki, K. (1999) · Hepatology · doi:10.1002/hep.510290636 · Cited by 208
Yamada, T., De Souza, A. T., Finkelstein, S., & Jirtle, R. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10351 · Cited by 208
p16INK4 is inactivated by extensive CpG methylation in human hepatocellular carcinoma
Matsuda, Y., Ichida, T., Matsuzawa, J., Sugimura, K., & Asakura, H. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70137-x · Cited by 202
Stem cells, asymmetric division and cancer
Clevers, H. (2005) · Nature Genetics · doi:10.1038/ng1005-1027 · Cited by 201
Wang, Y., Wu, M., Sham, J. S. T., Zhang, W., Wu, W., & Guan, X. (2002) · Cancer · doi:10.1002/cncr.10963 · Cited by 198
Inagawa, S., Itabashi, M., Adachi, S., Kawamoto, T., Hori, M., Shimazaki, J., Yoshimi, F., & Fukao, K. (2002) · PubMed · Cited by 196
Jiang, X., Hitchcock, A., Bryan, E. J., Watson, R. H., Englefield, P., Thomas, E. J., & Campbell, I. (1996) · PubMed · Cited by 190
Strategies for manipulating the p53 pathway in the treatment of human cancer
Hupp, T. R., Lane, D. P., & Ball, K. L. (2000) · Biochemical Journal · doi:10.1042/bj3520001 · Cited by 173
Lunn, R. M., Zhang, Y. J., Wang, L., Chen, C., Lee, P., Lee, C. S., Tsai, W. Y., & Santella, R. M. (1997) · PubMed · Cited by 170
Moinzadeh, P., Breuhahn, K., Stützer, H., & Schirmacher, P. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602448 · Cited by 169
Zhang, X., Xu, H. J., Murakami, Y., Sachse, R., Yashima, K., Hirohashi, S., Hu, S., Benedict, W. F., & Sekiya, T. (1994) · PubMed · Cited by 168
Smad2 and Smad4 gene mutations in hepatocellular carcinoma
Yakicier, M. C., Irmak, M. B., Romano, A., Kew, M., & Ozturk, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202866 · Cited by 167
Huether, A., Höpfner, M., Sutter, A. P., Schuppan, D., & Scherübl, H. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.040 · Cited by 167
Huether, A., Höpfner, M., Baradari, V., Schuppan, D., & Scherübl, H. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.09.007 · Cited by 166
Legoix, P., Bluteau, O., Bayer, J., Perret, C., Balabaud, C., Belghiti, J., Franco, D., Thomas, G., Laurent-Puig, P., & Zucman-Rossi, J. (1999) · Oncogene · doi:10.1038/sj.onc.1202800 · Cited by 162
Oloumi, A., McPhee, T., & Dedhar, S. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2003.12.002 · Cited by 162
Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma
Miura, H., Miyazaki, T., Kuroda, M., Oka, T., Machinami, R., Kodama, T., Shibuya, M., Makuuchi, M., Yazaki, Y., & Ohnishi, S. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80323-6 · Cited by 158
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics
Pecorino, L. T. (2005) · Cited by 155
Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
Nishida, N., Fukuda, Y., Kokuryu, H., Toguchida, J., Yandell, D. W., Ikenega, M., Imura, H., & Ishizaki, K. (1993) · PubMed · Cited by 151
The role of TGF-β and Wnt signaling in gastrointestinal stem cells and cancer
Mishra, L., Shetty, K., Tang, Y., Stuart, A., & Byers, S. W. (2005) · Oncogene · doi:10.1038/sj.onc.1208924 · Cited by 151
Lees, C. W., Howie, S., Sartor, R. B., & Satsangi, J. J. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.010 · Cited by 139
Terris, B., Pineau, P., Brégeaud, L., Valla, D. C., Belghiti, J., Tiollais, P., Degott, C., & Dejean, A. (1999) · Oncogene · doi:10.1038/sj.onc.1203051 · Cited by 131
Patil, M. A., Gütgemann, I., Zhang, J., Ho, C., Cheung, S., Ginzinger, D. G., Li, R., Dykema, K. J., So, S. K., Fan, S.-T., et al. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi178 · Cited by 129
INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas
Tannapfel, A., Busse, C., Weinans, L., Benicke, M., Katalinic, A., Geißler, F., Hauss, J., & Wittekind, C. (2001) · Oncogene · doi:10.1038/sj.onc.1204902 · Cited by 129
Wong, Y. F., Selvanayagam, Z., Wei, N., Porter, J. F., Vittal, R., Hu, R., Lin, Y., Liao, J. J. Z., Shih, J. W., Cheung, T. H., et al. (2003) · PubMed · Cited by 126
Hanafusa, T., Yumoto, Y., Nouso, K., Nakatsukasa, H., Onishi, T., Fujikawa, T., 谷山真由美, Nakamura, S., Uemura, M., Takuma, Y., et al. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00736-4 · Cited by 126
Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation.
Tanaka, S., Toh, Y., Adachi, E., Matsumata, T., Mori, R., & Sugimachi, K. (1993) · PubMed · Cited by 123
Liver stem cells and model systems for liver repopulation
Shafritz, D. A., & Dabeva, M. D. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00013-2 · Cited by 121
PTEN/MMAC1 mutations in hepatocellular carcinomas
Yao, Y. J., Ping, X. L., Zhang, H., Chen, F. F., Lee, P. K., Ahsan, H., Chen, C., Lee, P., Peacocke, M., Santella, R. M., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202659 · Cited by 121
Transforming growth factor‐β1 as a useful serologic marker of small hepatocellular carcinoma
Song, B., Chung, Y., Kim, J. A., Choi, W.-B., Suh, D. D., Pyo, S. I., Shin, J. W., Lee, H. C., Lee, Y. S., & Suh, D. J. (2001) · Cancer · doi:10.1002/cncr.10170 · Cited by 120
Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis
Wang, W., Yang, L.-Y., Huang, G.-W., Lu, W.-Q., Yang, Z.-L., Yang, J.-Q., & Liu, H. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601749 · Cited by 120
Molecular-based prediction of early recurrence in hepatocellular carcinoma
Kurokawa, Y., Matoba, R., Takemasa, I., Nagano, H., Dono, K., Nakamori, S., Umeshita, K., Sakon, M., Ueno, N., Oba, S., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.04.031 · Cited by 120
Farazi, P. A., Glickman, J. N., Horner, J. W., & DePinho, R. A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4608 · Cited by 119
Prange, W., Breuhahn, K., Fischer, F. F., Zilkens, C., Pietsch, T., Petmecky, K., Eilers, R., Dienes, H., & Schirmacher, P. (2003) · The Journal of Pathology · doi:10.1002/path.1448 · Cited by 112
Cui, J., Zhou, X., Liu, Y., Tang, Z., & Romeih, M. H. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.02973.x · Cited by 109
Yoshiji, H., Kuriyama, S., Yoshii, J., Ikenaka, Y., Noguchi, R., Hicklin, D. J., Wu, Y. L., Yanase, K., Namisaki, T., Kitade, M., et al. (2004) · Hepatology · doi:10.1002/hep.20218 · Cited by 106
Honda, K., Sbisà, E., Tullo, A., et al. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.126 · Cited by 105
Molecular karyotyping of human hepatocellular carcinoma using single-nucleotide polymorphism arrays
Midorikawa, Y., Yamamoto, S., Ishikawa, S., Kamimura, N., Igarashi, H., Sugimura, H., Makuuchi, M., & Aburatani, H. (2006) · Oncogene · doi:10.1038/sj.onc.1209537 · Cited by 105
Jackson, P. E., Qian, G., Friesen, M. D., Zhu, Y. R., Lu, P., Wang, J. B., Wu, Y., Kensler, T. W., Vogelstein, B., & Groopman, J. D. (2001) · PubMed · Cited by 105
β‐Catenin Accumulation and Mutation of Exon 3 of the β‐Catenin Gene in Hepatocellular Carcinoma
Kondo, Y., Kanai, Y., Sakamoto, M., Genda, T., Mizokami, M., Ueda, R., & Hirohashi, S. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00712.x · Cited by 102
橋本, 毅., Mori, N., Tamesa, T., Okada, T., Kawauchi, S., Oga, A., Furuya, T., Tangoku, A., Oka, M., & Sasaki, K. (2004) · Modern Pathology · doi:10.1038/modpathol.3800107 · Cited by 101
Su, Q., Liu, Y., Zhang, J., Zhang, S.-X., Li, D., & Yang, J.-J. (1994) · Hepatology · doi:10.1002/hep.1840200404 · Cited by 100
p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from thailand
Hollstein, M. C., Wild, C. P., Bleicher, F., Chutimataewin, S., Harris, C. C., Srivatanakul, A., & Montesano, R. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910530111 · Cited by 98
Ishizaki, Y., Ikeda, S., Fujimori, M., Shimizu, Y., Kurihara, T., Itamoto, T., Kikuchi, A., Okajima, M., & Asahara, T. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.5.1077 · Cited by 93
Skin Carcinoma Arising From Donor Cells in a Kidney Transplant Recipient
Aractingi, S., Kanitakis, J., Euvrard, S., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2783 · Cited by 93
Molecular Profiling of Hepatocellular Carcinomas (HCC) Using a Large-Scale Real-Time RT-PCR Approach
Paradis, V., Bièche, I., Dargère, D., et al. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63700-5 · Cited by 89
Vautier, G., Bomford, A. B., Portmann, B. C., Metivier, E. M., Williams, R. L., & Ryder, S. D. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70562-7 · Cited by 88
Chaubert, P., Gayer, R., Zimmermann, A., Fontolliet, C., Stamm, B., Bosman, F. T., & Shaw, P. H. (1997) · Hepatology · doi:10.1002/hep.510250613 · Cited by 88
Iizuka, N., Oka, M., Yamada‐Okabe, H., Mori, N., Tamesa, T., Okada, T., Takemoto, N., 橋本, 毅., Tangoku, A., Hamada, K., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206401 · Cited by 85
Buetow, K. H., Sheffield, V. C., Zhu, M., Zhou, T., Shen, F. M., Hino, O., Smith, M. A., McMahon, B. J., Lanier, A., & London, W. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9622 · Cited by 83
Mutations of β‐catenin and AXIN I genes are a late event in human hepatocellular carcinogenesis
Park, J. Y., Park, W. S., Nam, S. W., Kim, S. Y., Lee, S. H., Yoo, N. J., Lee, J. Y., & Park, C. K. (2005) · Liver International · doi:10.1111/j.1478-3231.2004.0995.x · Cited by 81
PTEN/MMAC1 mutations in primary glioblastomas and short-term cultures of malignant gliomas
Chiariello, E., Roz, L., Albarosa, R., Magnani, I., & Finocchiaro, G. (1998) · Oncogene · doi:10.1038/sj.onc.1201689 · Cited by 81
Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma.
Ikeguchi, M., Ueta, T., YAMANE, Y., Hirooka, Y., & Kaibara, N. (2002) · PubMed · Cited by 80
Disrupted IGF2 promoter control by silencing of promoter P1 in human hepatocellular carcinoma.
Li, X., Nong, Z., Ekström, C., Larsson, E., Nordlinder, H., Hofmann, W. J., Trautwein, C., Odenthal, M., Dienes, H., Ekström, T. J., et al. (1997) · PubMed · Cited by 79
Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas
竹尾, さ., Arai, H., Kusano, N., Harada, T., Furuya, T., Kawauchi, S., Oga, A., Hirano, T., Yoshida, T., Okita, K., et al. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00479-4 · Cited by 78
Molecular prognostication of liver cancer: End of the beginning
Thorgeirsson, S. S., Lee, J., & Grisham, J. W. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.01.008 · Cited by 77
Weihrauch, M., Benicke, M., Lehnert, G., Wittekind, C., Wrbitzky, R., & Tannapfel, A. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1675 · Cited by 77
Low Incidence of Point Mutation of c‐Ki‐ras and N‐ras Oncogenes in Human Hepatocellular Carcinoma
Tsuda, H., Hirohashi, S., Shimosato, Y., Ino, Y., Yoshida, T., & Terada, M. (1989) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1989.tb02290.x · Cited by 74
Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients
Tanaka, Y., Kanai, F., Tada, M., Asaoka, Y., Guleng, B., Jazag, A., Ohta, M., Ikenoue, T., Tateishi, K., Obi, S., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1209311 · Cited by 74
Huang, J. J., Sheng, H., Shen, T., Hu, Y., Xiao, H., Zhang, Q., Zhang, Q., & Han, Z. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.05.032 · Cited by 71
Higashitsuji, H., Higashitsuji, H., Nagao, T., Nonoguchi, K., Fujii, S., Itoh, K., & Fujita, J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00152-6 · Cited by 70
Katoh, H., Shibata, T., Kokubu, A., Ojima, H., Loukopoulos, P., Kanai, Y., Kosuge, T., Fukayama, M., Kondo, T., Sakamoto, M., et al. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.05.033 · Cited by 69
Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
Hosono, S., Chou, M. J., Lee, C., et al. (1993) · PubMed · Cited by 68
M6P/IGF2R tumor suppressor gene mutated in hepatocellular carcinomas in Japan
Oka, Y., Waterland, R. A., Killian, J. K., Nolan, C. M., Jang, H.-S., Tohara, K., Sakaguchi, S., Yao, T., Iwashita, A., Yata, Y., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.32669 · Cited by 65
Nardone, G., Romano, M., Calabrò, A., Pedone, P. V., de Sio, I., Persico, M., Budillon, G., Bruni, C. B., Riccio, A., & Zarrilli, R. (1996) · Hepatology · doi:10.1002/hep.510230602 · Cited by 62
Multiple chromosomal abnormalities in human liver (pre)neoplasia
Raidl, M., Pirker, C., Schulte‐Hermann, R., Aubele, M. M., Kandioler-Eckersberger, D., Wrba, F., Micksche, M., Berger, W., & Grasl‐Kraupp, B. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.12.020 · Cited by 62
Infrequent point mutations in codons 12 and 61 of ras oncogenes in human hepatocellular carcinomas
Challen, C., Guo, K., Collier, J. D., Cavanagh, D. R., & Bassendine, M. F. (1992) · Journal of Hepatology · doi:10.1016/0168-8278(92)90181-n · Cited by 61
Fujiwara, Y., Hoon, D. S. �., Yamada, T., Umeshita, K., Gotoh, M., Sakon, M., Nishisho, I., & Monden, M. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00943.x · Cited by 59
Absence of epidermal growth factor receptor exon 18–21 mutation in hepatocellular carcinoma
Su, M.-C., Lien, H., & Jeng, Y. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.10.010 · Cited by 54
Lemmer, E. R., Friedman, S. L., & Llovet, J. M. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-951604 · Cited by 52
Self-citationOgata, N., Kamimura, T., & Asakura, H. (1991) · Hepatology · doi:10.1002/hep.1840130106 · Cited by 47
Ефимова, Е. А., Glanemann, M., Liu, L., Schumacher, G., Settmacher, U., Jonas, S., Langrehr, J. M., Neuhaus, P., & Nussler, A. K. (2004) · European Surgical Research · doi:10.1159/000079915 · Cited by 47
Assessment of chromosomal losses and gains in hepatocellular carcinoma
Chang, J., Kim, N.-G., Piao, Z. H., Park, C., Park, K., Paik, Y., Lee, W. J., Kim, B. R., & Kim, H. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00083-6 · Cited by 44
Sugo, H., Takamori, S., Kojima, K., Beppu, T., & Futagawa, S. (1999) · Surgery Today · doi:10.1007/bf02482774 · Cited by 42
Analysis of differentially expressed genes in hepatocellular carcinoma using cDNA arrays
Goldenberg, D., Ayesh, S. K., Schneider, T., Pappo, O., Jurim, O., Eid, A., Fellig, Y., Dadon, T., Ariel, I., GROOT, N. D., et al. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10027 · Cited by 41
Sy, S. M.-H., Wong, N., Lai, P. B. S., To, K., & Johnson, P. J. (2004) · Modern Pathology · doi:10.1038/modpathol.3800345 · Cited by 41
Anders, R. A., Yerian, L. M., Tretiakova, M., Davison, J. M., Quigg, R. J., Domer, P. H., Hoberg, J. E., & Hart, J. A. L. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63893-x · Cited by 40
Selden, C., Farnaud, S., Ding, S. F., Habib, N. A., Foster, C. S., & Hodgson, H. J. F. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80400-3 · Cited by 38
Kubicka, S., Trautwein, C., Schrem, H., Tillmann, H. L., & Manns, M. P. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80199-5 · Cited by 37
Cui, J., Zhou, X., Liu, Y., & Tang, Z. (2001) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320100259 · Cited by 30
Microsatellite Instability and p53 Mutations in Hepatocellular Carcinoma
Karachristos, A., Liloglou, T., Field, J. K., et al. (1999) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.1999.0170 · Cited by 27
SHORT COMMUNICATION: p53 mutations in hepatocellular carcinoma related to oral contraceptive use
Benedetti, V. M. G. D., Welsh, J. A., Yu, M. C., & Bennett, W. P. (1996) · Carcinogenesis · doi:10.1093/carcin/17.1.145 · Cited by 27
Mutation Analysis of the Putative Tumor Suppressor GenePTEN/MMAC1in Hepatocellular Carcinoma
Yeh, K.-T., Chang, J., Chen, Y., Chen, S., Yu, S., Shih, M., Perng, L.-L., Wang, J., Tsai, M., & Chang, C. (2000) · Cancer Investigation · doi:10.3109/07357900009038243 · Cited by 27
Intracellular signalling and cancer: complex pathways lead to multiple targets
Bell, H. S., & Ryan, K. M. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2004.10.022 · Cited by 25
Anzola, M., Saiz, A., Cuevas, N., López‐Martínez, M., de Pancorbo, M. A. M., & Burgos, J. (2004) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2004.00541.x · Cited by 23
Microsatellite alterations in hepatocellular carcinoma and intrahepatic cholangiocarcinoma
Koo, S. H., Ihm, C. H., Kwon, K. C., Lee, J. S., Park, J. W., & Kim, J. W. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00133-x · Cited by 18
p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Cited by
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
Self-citationEASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
European Association for the Study of the Liver, & European Organisation for Research and Treatment of Cancer (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.12.001 · Cited by 5,218
“%) present with abnormal AFP serum levels, a fact that has been recently correlated with a molecular subclass of aggressive HCCs (S2 class, EpCAM positive) [77–79].”
BackgroundInfluentialForner, A., Llovet, J. M., & Bruix, J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61347-0 · Cited by 4,022
Self-citationWilhelm, S. M., Adnane, L., Newell, P., Villanueva, A., Llovet, J. M., & Lynch, M. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0013 · Cited by 1,459
Self-citationHoshida, Y., Nijman, S. M. B., Kobayashi, M., Chan, J. A., Brunet, J.-P., Chiang, D. Y., Villanueva, A., Newell, P., Ikeda, K., Hashimoto, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1089 · Cited by 1,238
“This complexity makes it difficult to identify the causal genetic events promoting HCC development and progression (2, 3).”
BackgroundSelf-citation
Metadata
- Authors
- Villanueva, A., Newell, P., Chiang, D., Friedman, S., & Llovet, J.
- Venue
- Seminars in Liver Disease
- Publisher
- Georg Thieme Verlag KG
- Published
- 2007-02
- Volume
- 27
- Issue
- 1
- Pages
- 055-076
- ISSN
- 0272-8087 (ISSN-L)
- 1098-8971
- OpenAlex
- W2067691895
- Cited by
- 556
- References
- 186
- FWCI
- 29.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.